Member Log-in

I forgot my password

Not a Member? Register

How Immunization Professionals Can Address Infection Prevention and Control (IPC) During COVID-19

May 29, 2020

The World Health Organization (WHO) and the Boost Community, in partnership with TechNet-21 and The Geneva Learning Foundation, are happy to offer an interactive webinar: How Immunization Professionals Can Address Infection Prevention and Control (IPC) During COVID-19. This webinar will take place Friday, May 29 at 3:00 PM CEST. Experts from WHO will explain how immunization professionals can operationalize WHO guidance on IPC. Webinar participants will have an opportunity to ask questions and share experiences on how they are addressing IPC matters in their own contexts. Register here.

Send your questions related for WHO IPC experts in advance to You can also join the conversation in our Boost Learning Group on COVID-19.

You May Also Like

Immunization in the Time of COVID-19: The critical role of community voices in building global resilience against pandemics and maintaining essential services

An Online conversation hosted by Gavi CSO Constituency in partnership with ACTION, Gavi, the Vaccine Alliance, PATH, RESULTS UK & Save the Children 15h00 (CET) on Thursday14th May 2020 The event will be streamed live in English and French Follow the link to join: The COVID-19 pandemic is claiming lives across the globe and … Continued

LNCT WEBINAR: Designing Behavioural Strategies for Immunization in a Covid-19 Context

Please join us on Thursday May 21, 2020 for a LNCT webinar, ‘Designing Behavioral Strategies for Immunization in a Covid-19 Context.’ Hosted by Common Thread, this webinar will review the Covid-19 context that many GAVI countries now find themselves in. This new Covid-19 context, underpinned by the way in which citizens: perceive Government guidelines and … Continued

Considerations for Future SARS-CoV-2 Vaccines: A Private Sector Perspective

Several vaccine candidates are being tested to help address the ongoing COVID-19 pandemic. Uncertainty remains about key epidemiologic factors to characterize the disease, including true infection rate, proportion of symptomatic cases, and potential for re-infection. As the virus spreads and data continue to develop, the potential role of vaccination will continue to evolve. This presentation … Continued

Choose a Language